Shiji Fang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 7
- Cancer, Hypoxia, and Metabolism 7
- MicroRNA in disease regulation 6
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 10
-
- Ferroptosis and cancer prognosis 15
- Molecular Biology top 10%
- RNA modifications and cancer 8
- Circular RNAs in diseases 7
- Biomaterials top 10%
-
- Nanoplatforms for cancer theranostics 9
Shiji Fang
60 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 490
- Hepatology 238
- Pulmonary and Respiratory Medicine 487
- Molecular Biology 828
- Biomaterials 141
Countries citing papers authored by Shiji Fang
This map shows the geographic impact of Shiji Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiji Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiji Fang more than expected).
Fields of papers citing papers by Shiji Fang
This network shows the impact of papers produced by Shiji Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiji Fang. The network helps show where Shiji Fang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shiji Fang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 19 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 14 | |
| 9 | 2022 | 17 | |
| 10 | 2022 | 45 | |
| 11 | Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Responsebreakdown → | 2022 | 145 |
| 12 | 2021 | 15 | |
| 13 | 2021 | 97 | |
| 14 | 2021 | 11 | |
| 15 | 2021 | 69 | |
| 16 | 2021 | 11 | |
| 17 | 2020 | 27 | |
| 18 | 2020 | 1 | |
| 19 | 2020 | 50 | |
| 20 | 2019 | 6 |
About Shiji Fang
Shiji Fang is a scholar working on Cancer Research, Hepatology and Pulmonary and Respiratory Medicine, having authored 63 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Nanoplatforms for cancer theranostics (9 papers), RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers), Cancer, Hypoxia, and Metabolism (7 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (490 citations), Hepatology (238 citations) and Pulmonary and Respiratory Medicine (487 citations). Shiji Fang has collaborated with scholars based in China, Germany and Japan. Frequent co-authors include Jiansong Ji, Minjiang Chen, Zhongwei Zhao, Qiaoyou Weng, Bufu Tang, Liyun Zheng, Gaofeng Shu, Jinyu Zhu, Jingjing Song and Jianfei Tu. Their work appears in journals such as Frontiers in Oncology, Biomaterials Science, ACS Applied Materials & Interfaces, Cell Death and Disease and Military Medical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.